Amber Bio
Pharmaceutical Manufacturing
21 employees
- Employees
- 21
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Amber Bio Overview
- Website
- www.amber.bio
- Industry
- Pharmaceutical Manufacturing
- Employees
- 21
- Funding
- 26.0M
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Amber Bio
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Amber Bio Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Amber Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jacob Borrajo | CEO at Amber Bio | San Francisco, California, United States |
Email
Phone
|
| Nicholas Reynolds | Development Scientist - Upstream | Richmond, California, United States |
Email
|
| Rusty Kelley | Managing Director, Rd Fund | Durham, North Carolina, United States |
Email
|
| Benjamin Kim | Partner at Playground Global | Stanford, California, United States |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to Amber Bio
Denali Therapeutics
Biotechnology Research
Xaira Therapeutics
Biotechnology Research
Octant
Biotechnology Research
Inceptive
Biotechnology Research
Nitra
Financial Services
Synonym
Biotechnology
Taxa
Biotechnology Research
Arda Therapeutics
Biotechnology Research
Scribio
Biotechnology Research
Coral (acquihired)
Biotechnology Research